Company / Interest Expense
CLOVER HEALTH INVESTMENTS, CORP. /DE Interest Expense History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$7.0K
FY2023
5-year range
$7.0K / $3.2M
FY2019-FY2023
Trend
-99.5%
vs FY2022
Sector context
#44 of 46
Health Care
What the data says
Among 46 Health Care companies, CLOVER HEALTH INVESTMENTS, CORP. /DE is in the top 4% for interest expense. Interest Expense has declined for 3 consecutive years, from $36M in FY2020 to $7,000 in FY2023.
Based on SEC 10-K filings.
$7,000 in FY2023 with a 3-year CAGR of -94.2%.
Improved from $3M to $7,000 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -94.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 46This company $7.0K Sector average $293.8M
▼
-100.0% below sector average
Key checks
Key Insights
- CLOVER HEALTH INVESTMENTS, CORP. /DE's interest expense has declined for 3 consecutive years.
- 3-year CAGR of -94.2%, indicating a declining trend.
- In FY2023, interest expense decreased 99.5% year-over-year.
- Ranks #44 out of 46 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $7.0K | -99.5% |
| FY2022 | $1.3M | -58.3% |
| FY2021 | $3.2M | -91.1% |
| FY2020 | $36.0M | +55.4% |
| FY2019 | $23.2M | - |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026